Us Bancorp \De\ Takeda Pharmaceutical CO LTD Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 124,332 shares of TAK stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,332

Previous 102,588 21.2%

Holding current value

$1.69 Million

Previous $1.46 Million 12.97%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$13.01 - $14.43 $282,889 - $313,765	21,744 Added 21.2%	124,332 $1.65 Million
Q3 2024 Oct 28, 2024	BUY	$13.0 - $15.08 $142,025 - $164,749	10,925 Added 11.92%	102,588 $1.46 Million
Q2 2024 Aug 06, 2024	SELL	$12.6 - $13.67 $308,246 - $334,422	-24,464 Reduced 21.07%	91,663 $1.19 Million
Q1 2024 May 07, 2024	BUY	$13.89 - $15.04 $325,720 - $352,688	23,450 Added 25.3%	116,127 $1.61 Million
Q4 2023 Feb 09, 2024	SELL	$13.36 - $15.43 $50,554 - $58,387	-3,784 Reduced 3.92%	92,677 $1.32 Million
Q3 2023 Nov 03, 2023	SELL	$15.03 - $16.32 $1.28 Million - $1.39 Million	-85,298 Reduced 46.93%	96,461 $1.49 Million
Q2 2023 Aug 09, 2023	SELL	$15.57 - $17.11 $640,129 - $703,443	-41,113 Reduced 18.45%	181,759 $2.86 Million
Q1 2023 May 09, 2023	BUY	$15.28 - $16.48 $302,268 - $326,007	19,782 Added 9.74%	222,872 $3.67 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $1.25 Million - $1.58 Million	101,045 Added 99.02%	203,090 $3.17 Million
Q3 2022 Oct 27, 2022	BUY	$12.8 - $28.65 $16,665 - $37,302	1,302 Added 1.29%	102,045 $1.32 Million
Q2 2022 Aug 01, 2022	SELL	$13.12 - $15.03 $301,563 - $345,464	-22,985 Reduced 18.58%	100,743 $1.41 Million
Q1 2022 May 11, 2022	BUY	$13.54 - $15.35 $220,674 - $250,174	16,298 Added 15.17%	123,728 $1.77 Million
Q4 2021 Feb 11, 2022	BUY	$13.17 - $16.4 $372,724 - $464,136	28,301 Added 35.77%	107,430 $1.47 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $405,038 - $428,893	24,849 Added 45.78%	79,129 $1.3 Million
Q2 2021 Aug 05, 2021	BUY	$16.55 - $18.64 $1,870 - $2,106	113 Added 0.21%	54,280 $914,000
Q1 2021 Apr 28, 2021	BUY	$16.71 - $19.9 $116,301 - $138,504	6,960 Added 14.74%	54,167 $989,000
Q4 2020 Feb 04, 2021	BUY	$15.39 - $18.97 $29,179 - $35,967	1,896 Added 4.18%	47,207 $859,000
Q3 2020 Nov 10, 2020	BUY	$17.1 - $19.19 $104,361 - $117,116	6,103 Added 15.57%	45,311 $808,000
Q2 2020 Aug 07, 2020	BUY	$14.59 - $19.5 $103,530 - $138,372	7,096 Added 22.1%	39,208 $703,000
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $179,298 - $279,689	-13,771 Reduced 30.01%	32,112 $487,000
Q4 2019 Feb 04, 2020	SELL	$16.88 - $20.83 $91,793 - $113,273	-5,438 Reduced 10.6%	45,883 $905,000
Q3 2019 Nov 08, 2019	BUY	$16.15 - $17.99 $129,296 - $144,027	8,006 Added 18.48%	51,321 $882,000
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $223,548 - $276,266	-13,483 Reduced 23.74%	43,315 $766,000
Q1 2019 May 08, 2019	BUY	$16.7 - $21.52 $730,591 - $941,456	43,748 Added 335.23%	56,798 $1.16 Million
Q4 2018 Feb 13, 2019	BUY	$15.64 - $21.1 $204,102 - $275,355	13,050 New	13,050 $220,000

Others Institutions Holding TAK

# of Institutions

333

Shares Held

66.7M

Call Options Held

1.99M

Put Options Held

155K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account